Assessment and management of chronic obstructive pulmonary disease in the emergency department and beyond

References

• Stoller JK. Clinical practice. Acute exacerbations of chronic obstructive pulmonary disease. N. Engl. J. Med.346, 988–994 (2002).
   PubMed Web of Science ®Google Scholar
• Anthonisen N, Manfreda J, Warren P et al. Antibiotic therapy in exacerbation of chronic obstructive pulmonary disease. Ann. Intern. Med.106, 196–204 (1987).
   PubMed Web of Science ®Google Scholar
• Mannino DM, Homa DM, Akinbami LJ et al. Chronic obstructive pulmonary disease surveillance – United States, 1971–2000. CDC Surveillance Summaries, MMWR51, 1–16 (2002).
   Google Scholar
• O’Donnell DE, Aaron S, Bourbeau J et al. Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease – 2007 update. Can. Respir. J.14, 5B–32B (2007).
   PubMed Web of Science ®Google Scholar
• Donaldson GC, Seemungal TA, Bhowmik A, Wedzicha JA. Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax57, 847–852 (2002).
   PubMed Web of Science ®Google Scholar
• Seemungal TA, Donaldson GC, Paul EA et al. Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med.157, 1418–1422 (1998).
   PubMed Web of Science ®Google Scholar
• Almagro P, Calbo E, Ochoa de Echaguen A et al. Mortality after hospitalization for COPD. Chest121, 1441–1448 (2002).
   PubMed Web of Science ®Google Scholar
• Groenewegen KH, Schols AM, Wouters EF. Mortality and mortality-related factors after hospitalization for acute exacerbation of COPD. Chest124, 459–467 (2003).
   PubMed Web of Science ®Google Scholar
• Fitzgerald JM, Haddon JM, Bradly-Kennedy C et al. Resource use study in COPD (RUSIC): a prospective study to quantify the effects of COPD exacerbations on health care resource use among COPD patients. Can. Respir. J.14, 145–52 (2007).
   PubMed Web of Science ®Google Scholar
• Hurst JR, Vestbo J, Anzueto A et al. Susceptibility to exacerbation in chronic obstructive pulmonary disease. N. Engl. J. Med.363, 1128–1138 (2010).
   PubMed Web of Science ®Google Scholar
• Aaron SD, Vandemheen KL, Hebert P et al. Outpatient oral prednisone after emergency treatment of chronic obstructive pulmonary disease. N. Engl. J. Med.348, 8 (2003).
   Google Scholar
• Cydulka RK, Rowe BH, Clark S et al. Emergency department management of acute exacerbations of chronic obstructive pulmonary disease in the elderly: the Multicenter Airway Research Collaboration. J. Am. Geriatr. Soc.51, 908–916 (2003).
   PubMed Web of Science ®Google Scholar
• Balter MS, LaForge J, Low DE et al. The chronic bronchitis working group on behalf of the canadian thoracic society and the canadian infectious disease society. Canadian guidelines for the management of acute exacerbations of chronic bronchitis. Can. Respir. J.10, 3B–32B (2003).
   PubMedGoogle Scholar
• Roche N, Lepage T, Bourcereau J, Terrioux P. Guidelines versus clinical practice in the treatment of chronic obstructive pulmonary disease. Eur. Respir. J.18, 903–908 (2001).
   PubMed Web of Science ®Google Scholar
• Laitinen LA, Koskela K. Chronic bronchitis and chronic obstructive pulmonary disease: Finnish National Guidelines for Prevention and Treatment 1998–2007. Respir. Med.93, 297–332 (1999).
   PubMed Web of Science ®Google Scholar
• The COPD Guidelines Group of the Standard of Care Committee of the BTS. BTS Guidelines for the Management of Chronic Obstructive Pulmonary Disease. Thorax52, S1–S28 (1997).
   PubMed Web of Science ®Google Scholar
• American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am. J. Resp. Crit. Care152, S77–S120 (1995).
   PubMed Web of Science ®Google Scholar
• Cabana MD, Rand CS, Powe NR et al. Why don’t physicians follow clinical practice guidelines? A framework for improvement. JAMA282, 1458–1465 (1999).
   PubMed Web of Science ®Google Scholar
• Carlbom DJ, Rubenfeld GD. Barriers to implementing protocol-based sepsis resuscitation in the emergency department-results of a national survey. Crit. Care Med.35, 2525–2532 (2007).
   PubMed Web of Science ®Google Scholar
• Radeos MS, Cydulka RK, Rowe BH et al. Validation of self-reported chronic obstructive pulmonary disease among patients in the ED. Am. J. Emerg. Med.27, 191–196 (2009).
   PubMed Web of Science ®Google Scholar
• Hardie JA, Buist AS, Vollmer WM et al. Risk of over-diagnosis of COPD in asymptomatic elderly never-smokers. Eur. Respir. J.20, 1117–1122 (2002).
   PubMed Web of Science ®Google Scholar
• Celli BR, Cote CG, Marin JM et al. The body-mass index, airflow obstruction, dyspnea and exercise capacity index in chronic obstructive pulmonary disease. N. Engl. J. Med.350, 1005–1012 (2004).
   PubMed Web of Science ®Google Scholar
• Fletcher CM, Elmes PC, Fairbairn AS, Wood CH. The significance of respiratory symptoms and the diagnosis of chronic bronchitis in a working population. Br. Med. J.2, 257–266 (1959).
   PubMed Web of Science ®Google Scholar
• Nishimura K, Izumi T, Tsukino M, Oga T. Dyspnea is a better predictor of 5-year survival than airway obstruction in patients with COPD. Chest121, 1434–1440 (2002).
   PubMed Web of Science ®Google Scholar
• Tsimogianni AM, Papiris SA, Stathopoulos GT et al. Predictors of outcome after exacerbation of chronic obstructive pulmonary disease. J. Gen. Intern. Med.24, 1043–1048 (2009).
   PubMed Web of Science ®Google Scholar
• Bullard MJ, Unger B, Spence J, Grafstein E. Revisions to the Canadian Emergency Department Triage and Acuity Scale (CTAS) adult guidelines. CJEM10, 136–151 (2008).
   PubMedGoogle Scholar
• Laitinen LA, Koskela K. Chronic bronchitis and chronic obstructive pulmonary disease: Finnish National Guidelines for Prevention and Treatment 1998–2007. Respir. Med.93, 297–332 (1999).
   PubMed Web of Science ®Google Scholar
• Ram FS, Wellington S, Rowe B, Wedzicha JA. Non-invasive positive pressure ventilation for treatment of respiratory failure due to severe acute exacerbations of asthma. Cochrane Database Syst. Rev.3, CD004360 (2005).
   Google Scholar
• McCrory DC, Brown CD. Anticholinergic bronchodilators versus β2-sympathomimetic agents for acute exacerbations of chronic obstructive pulmonary disease (Cochrane Review). Cochrane Database Syst. Rev.4, CD003900 (2003).
   Google Scholar
• Cates CJ, Crilly JA, Rowe BH. Holding chambers (spacers) versus nebulisers for β-agonist treatment of acute asthma. Cochrane Database Syst. Rev.2, CD000052 (2006).
   Google Scholar
• Yu I, Li Y, Wong TW et al. Evidence of airborne transmission of the severe acute respiratory syndrome virus. N. Engl. J. Med.350, 1731–1739 (2004).
   PubMed Web of Science ®Google Scholar
• Stoodley RG, Aaron SD, Dales RE. The role of ipratropium bromide in the emergency management of acute asthma exacerbation: a meta-analysis of randomized clinical trials. Ann. Emerg. Med.34, 8–18 (1999).
   PubMed Web of Science ®Google Scholar
• Easton PA, Jadue C, Dhingra S, Anthonisen NR. A comparison of the bronchodilating effects of a β-2 adrenergic agent (albuterol) and an anticholinergic agent (ipratropium bromide), given by aerosol alone or in sequence. N. Engl. J. Med.315, 735–739 (1986).
   PubMed Web of Science ®Google Scholar
• Routine nebulized ipratropium and albuterol together are better than either alone in COPD. The COMBIVENT Inhalation Solution Study Group. Chest112, 1514–1521 (1997).
   PubMed Web of Science ®Google Scholar
• Appleton S, Jones T, Poole P et al. Ipratropium bromide versus long-acting β-2 agonists for stable chronic obstructive pulmonary disease. Cochrane Database Syst. Rev.3, CD006101 (2006).
   Google Scholar
• Wood-Baker RR, Gibson PG, Hannay M et al. Systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst. Rev.1, CD001288 (2005).
   Google Scholar
• Bullard MJ, Liaw SJ, Tsai YH, Min HP. Early corticosteroid use in acute exacerbations of chronic airflow obstruction. Am. J. Emerg. Med.14, 139–143 (1996).
   PubMedGoogle Scholar
• Niewoehner DE, Erbland ML, Deupree RH et al. Effect of systemic glucocorticoids on exacerbations of chronic obstructive pulmonary disease. Department of Veterans Affairs Cooperative Study Group. N. Engl. J. Med.340, 1941–1947 (1999).
   PubMed Web of Science ®Google Scholar
• Varia M, Wilson S, Sarwal S et al. Investigation of a nosocomial outbreak of severe acute respiratory syndrome (SARS) in Toronto, Canada. CMAJ169, 285–292 (2003).
   PubMed Web of Science ®Google Scholar
• Sethi S, Evans N, Grant BJ, Murphy TF. New strains of bacteria and exacerbations of chronic obstructive pulmonary disease. N. Engl. J. Med.347, 465–471 (2002).
   PubMed Web of Science ®Google Scholar
• Monso E, Ruiz J, Rosell A et al. Bacterial infection in chronic obstructive pulmonary disease. A study of stable and exacerbated outpatients using the protected specimen brush. Am. J. Respir. Crit. Care Med.152, 1316–1320 (1995).
   PubMed Web of Science ®Google Scholar
• Murphy TF, Brauer AL, Schiffmacher AT, Sethi S. Persistent colonization by Haemophilus influenzae in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med.170, 266–272 (2004).
   PubMed Web of Science ®Google Scholar
• Ram FS, Rodriguez-Roisin R, Granados-Navarrete A et al. WITHDRAWN: antibiotics for exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst. Rev.1, CD004403 (2011).
   Google Scholar
• Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Pulmonary Disease. Copyright 2006 MCR Vision Inc. (2006).
   Google Scholar
• Balter MS, La Forge J, Low DE et al. Canadian guidelines for the management of acute exacerbations of chronic bronchitis: executive summary. Can. Respir. J.10, 248–258 (2003).
   PubMedGoogle Scholar
• Ram FSF, Picot J, Lightowler JV, Wedzicha JA. Non-invasive positive pressure ventilation for treatment of respiratory failure due to exacerbations of chronic obstructive pulmonary disease. Cochrane Database of Syst. Rev.3, CD004104 (2004).
   PubMedGoogle Scholar
• Bradley JM, Lasserson T, Elborn S et al. A systematic review of randomized controlled trials examining the short-term benefit of ambulatory oxygen in COPD. Chest131, 278–285 (2007).
   PubMed Web of Science ®Google Scholar
• Barr RG, Rowe BH, Camargo CA Jr. Methylxanthines for exacerbations of chronic obstructive pulmonary disease: meta-analysis of randomised trials. Br. Med. J.327, 643–649 (2003).
   PubMed Web of Science ®Google Scholar
• Rowe BH, Villa-Roel C, Guttman A et al. Predictors of hospital admission for chronic obstructive pulmonary disease exacerbations in Canadian emergency departments. Acad. Emerg. Med.16, 316–324 (2009).
   PubMedGoogle Scholar
• Tsai CL, Clark S, Cydulka RK et al. Factors associated with hospital admission among emergency department patients with chronic obstructive pulmonary disease exacerbation. Acad. Emerg. Med.14, 6–14 (2007).
   PubMed Web of Science ®Google Scholar
• El Moussaoui R, Roede BM, Speelman P et al. Short-course antibiotic treatment in acute exacerbations of chronic bronchitis and COPD: a meta-analysis of double-blind studies. Thorax63, 415–422 (2008).
   PubMed Web of Science ®Google Scholar
• Vanderkooi OG, Low DE, Green K et al. Predicting antimicrobial resistance in invasive pneumococcal infections. Clin. Inf. Dis.40, 1288–1297 (2005).
   PubMed Web of Science ®Google Scholar
• Garcia-Aymerich J, Barreiro E, Farrero E et al. Patients hospitalized for COPD have a high prevalence of modifiable risk factors for exacerbation (EFRAM study). Eur. Respir. J.16, 1037–1042 (2000).
   PubMed Web of Science ®Google Scholar
• Kim S, Emerman CL, Cydulka RK et al. Prospective multicenter study of relapse following emergency department treatment of COPD exacerbation. Chest125, 473–481 (2004).
   PubMed Web of Science ®Google Scholar
• Rowe BH, Voaklander DC, Marrie TJ et al. Outcomes following COPD presentations to emergency departments in Alberta, Canada: a population-based study. Can. Respir. J.17(6), 295–300 (2010).
   PubMedGoogle Scholar
• Wongsurakiat P, Maranetra KN, Wasi C et al. Acute respiratory illness in patients with COPD and the effectiveness of influenza vaccination: a randomized controlled study. Chest125, 2011–2020 (2004).
   PubMed Web of Science ®Google Scholar
• Poole PJ, Chacko E, Wood-Baker RW, Cates CJ. Influenza vaccine for patients with chronic obstructive pulmonary disease. Cochrane Database Syst. Rev.1, CD002733 (2006).
   PubMed Web of Science ®Google Scholar
• Granger R, Walters J, Poole PJ et al. Injectable vaccines for preventing pneumococcal infection in patients with chronic obstructive pulmonary disease. Cochrane Database Syst. Rev.4, CD001390 (2006).
   Google Scholar
• Alfageme I, Vazquez R, Reyes N et al. Clinical efficacy of anti-pneumococcal vaccination in patients with COPD. Thorax61, 189–195 (2006).
   PubMed Web of Science ®Google Scholar
• Fisman DN, Abrutyn E, Spaude KA et al. Prior pneumococcal vaccination is associated with reduced death, complications and length of stay among hospitalized adults with community-acquired pneumonia. Clin. Inf. Dis.42, 1093–1101 (2006).
   PubMed Web of Science ®Google Scholar
• Johnstone J, Marrie TJ, Eurich DT, Majumdar SR. Effect of pneumococcal vaccination in hospitalized adults with community-acquired pneumonia. Arch. Intern. Med.167, 1938–1943 (2007).
   PubMedGoogle Scholar
• Anthonisen NR, Connett JE, Kiley JP et al. Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study. JAMA272, 1497–1505 (1994).
   PubMed Web of Science ®Google Scholar
• Godtfredsen NS, Vestbo J, Osler M, Prescott E. Risk of hospital admission for COPD following smoking cessation and reduction: a Danish population study. Thorax57, 967–972 (2002).
   PubMed Web of Science ®Google Scholar
• Anthonisen NR, Connett JE, Murray RP. Smoking and lung function of Lung Health Study participants after 11 years. Am. J. Respir. Crit. Care Med.166, 675–679 (2002).
   PubMed Web of Science ®Google Scholar
• Pulmonary rehabilitation: Joint ACCP/AACVPR evidence-based guidelines. ACCP/AACVPR Pulmonary rehabilitation guidelines panel. American college of chest physicians. American association of cardiovascular and pulmonary rehabilitation. Chest112, 1363–1396 (1997).
   PubMed Web of Science ®Google Scholar
• Lacasse Y, Goldstein R, Lasserson TJ, Martin S. Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database Syst. Rev.4, CD003793 (2006).
   PubMedGoogle Scholar
• Maltais F, Bourbeau J, Shapiro S et al. Effects of home-based pulmonary rehabilitation in patients with chronic obstructive pulmonary disease: a randomized trial. Ann. Intern. Med.149, 869–878 (2008).
   PubMed Web of Science ®Google Scholar
• Puhan MA, Scharplatz M, Troosters T, Steurer J. Respiratory rehabilitation after acute exacerbations of chronic obstructive pulmonary disease. Intl J. Respir. Care2, 90–93 (2007).
   Google Scholar
• Behnke M, Taube C, Kirsten D et al. Home-based exercise is capable of preserving hospital-based improvements in severe chronic obstructive pulmonary disease. Respir. Med.94, 1184–1191 (2000).
   PubMed Web of Science ®Google Scholar
• Behnke M, Jorres RA, Kirsten D, Magnussen H. Clinical benefits of a combined hospital and home-based exercise programme over 18 months in patients with severe COPD. Monaldi Arch. Chest Dis.59, 44–51 (2003).
   PubMedGoogle Scholar
• Kirsten DK, Taube C, Lehnigk B et al. Exercise training improves recovery in patients with COPD after an acute exacerbation. Respir. Med.92, 1191–1198 (1998).
   PubMed Web of Science ®Google Scholar
• Nava S. Rehabilitation of patients admitted to a respiratory intensive care unit. Arch. Phys. Med. Rehabil.79, 849–854 (1998).
   PubMed Web of Science ®Google Scholar
• Man WD, Polkey MI, Donaldson N et al. Community pulmonary rehabilitation after hospitalisation for acute exacerbations of chronic obstructive pulmonary disease: randomised controlled study. Br. Med. J.329, 1209 (2004).
   PubMed Web of Science ®Google Scholar
• Murphy N, Bell C, Costello RW. Extending a home from hospital care programme for COPD exacerbations to include pulmonary rehabilitation. Respir. Med.99, 1297–1302 (2005).
   PubMed Web of Science ®Google Scholar
• Seymour JM, Moore L, Jolley CJ et al. Outpatient pulmonary rehabilitation following acute exacerbations of COPD. Thorax65, 423–428 (2010).
   PubMed Web of Science ®Google Scholar